Original Article
An Approach to Identify Rural Women Aged 60 to 64 for Osteoporosis Treatment
Abstract
Objectives: The US Preventive Services Task Force recently recommended that women younger than 65 years undergo a bone mineral density screening if clinical risk factors (CRFs) of a major osteoporotic fracture are ≥9.3% for a period of 10 years. We sought the most cost-effective approach to identify older, rural women who are eligible for osteoporosis treatment.
Methods: We evaluated CRFs and peripheral forearm densitometry (pDXA) in 277 rural women aged 60 to 64 years for treatment eligibility. We compared three strategies of universal screening—pDXA, CRFs, and exclusion of pDXA in specific situations (prior fracture and CRFs ≥20%)—followed by CRF evaluation with pDXA confirmation in the residual population.
Results: Our sample showed that 37.5% of women had CRFs at a ≥9.3% cutoff threshold. Only osteoporotic pDXA values were significantly higher at this threshold. Current estrogen use was significantly associated with diminished treatment eligibility (P = 0.001). Body mass index correlated poorly with pDXA values (r = 0.12) and CRFs (r = 0.21). Although a cost-savings strategy nonsignificantly identified more women who were eligible for treatment using the three strategies (P = 0.25), significantly fewer pDXA examinations were required (P < 0.001).
Conclusions: Initiating treatment in rural women aged 60 to 64 years who had a prior fracture or CRFs ≥20% without pDXA confirmation, followed by pDXA evaluations in the residual population with CRFs between ≥9.3% and 20%, significantly reduced the number of pDXA examinations and the cost of screening.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Melton LJ III, Crowson CS, O’Fallon WM. Fracture incidence in Olmstead County, Minnesota comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 1999; 9: 29–37.
2. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 2007; 22: 465–475.
3. Nguyen ND, Ahiborg HG, Center JR, et al. Residual lifetime risk of fractures in women and men. J Bone Miner Res 2007; 22: 781–788.
4. Adachi JA, Adami S, Gehlbach S, et al. Impact of prevalent fractures on quality of life: baseline results from the Global Longitudinal Study of Osteoporosis in Women. Mayo Clin Proc 2010; 85: 806–813.
5. Nelson HD, Helfand M, Woolf SH, et al. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Int Med 2002; 137: 529–541.
6. Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement. Ann Int Med 2011; 154: 356–364.
7. Kuehn BM. New tool measures 10-year fracture risk. JAMA 2008; 299: 1651–1652.
8. FRAX™ WHO Fracture Risk Assessment. Available at: www.shef.ac.uk/FRAX/tool.jsp. Accessed March 18, 2011.
9. Kanis JA, Johnell O, Oden A, et al. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 9385–9397.
10. Baim S, Binkley N, Bilizikian JP, et al. Official positions of the International Society of Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008; 11: 79–81.
11. Richards JR, Leslie WB, Joseph L, et al. Changes to osteoporosis prevalence according to the method of risk assessment. J Bone Miner Res 2007; 22: 228–234.
12. Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399–428.
13. Leslie WB, Majumdar SR, Lix LM, et al., for the Manitoba Bone Density Program. High fracture probability with FRAXR usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int 2011; 2.
14. Gilsanz V, Chalfant J, Mo AO, et al. Reciprocal relations of subcutaneous fat and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009; 94: 3387–3393.
15. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC, National Osteoporosis Foundation, 2008.
16. Lindsay R. Risk assessment using bone mineral density determination. Osteoporos Int 1998; 8: 28–31.
17. Blake GM, Fogelman I. Peripheral or central densitometry: does it matter which technique we use. J Clin Densitom 2001; 4: 83–96.
18. Blake GM, Knapp KMD, Fogelman I. Absolute fracture risk varies with bone mineral density determination. J Clin Densitom 2002; 5: 109–116.
19. Faulkner KG, van Stetter E, Miller PD. Discordance in patient population using T-scores. J Clin Densitom 1999; 2: 343–350.
20. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003; 18: 1947–1954.
21. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004; 164: 1108–1112.
22. Siris ES, Miller PD, Barrett-Conner E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. JAMA 2001; 286: 2815–2822.
23. Holberg A, Johnell O, Akesson K, et al. A forearm bone mineral density in 1294 middle age women. J Clin Densitom 2004; 7: 419–426.
24. Miller PD, Siris ES, Barrett-Conner E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 2002; 17: 2222–2230.
25. Donaldson MG, Cawthon PM, Liu LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic intervention by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res 2009; 24: 675–680.
26. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291: 47–53.
27. Rendu-Sornay E, Munoz F, Delmas PD, et al. The FRAX tool in French women: how well does it describe the real incidence of fracture in the OFELY cohort. J Bone Miner Res 2010; 25: 2101–2107.
28. Ensrud KE, Lui LY, Taylor B, et al. A comparison of prediction models for fractures in older women. Arch Intern Med 2009; 169: 2087–2094.
29. Donaldson MG, Palermo L, Schousboe JT, et al. FRAX and risk of vertebral fractures: the Fracture Intervention Trial. J Bone Miner Res 2009; 24: 1793–1799.
30. Gourlay ML, Powers JM, Lui L-Y, et al. Clinical performance of osteoporosis risk tools in women aged 67 years and older. Osteoporos Int 2008; 19: 1175–1183.
31. Tremollieres FA, Pouilles JM, Drewniak N, et al. Fracture risk predictionusing BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res 2010; 25: 1002–1009.
32. Bolland MG, Amanda TY, Mason BH, et al. Evaluation of FRAX and GARVAN risk calculations in older women. J Bone Miner Res 2011; 26: 420–427.
33. Leslie WE, Tsang JF, Lix LMfor the Manitoba Bone Density Program. Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res 2009; 24: 353–360.
34. Pluijm SMF, de Laet C, Van Schoor NM, et al. A simple risk score for assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res 2009; 24: 768–774.
35. Nguyen ND, Frost SA, Center JR, et al. Development of prognostic nomograms for individualizing five year and ten year fracture risks. Osteoporos Int 2008; 19: 431–444.
36. Brauer CA, Coca-Perraillion M, Cutler DM. Incidence and mortality of hip fractures in the United States. JAMA 2009; 302: 1573–1579.
37. Melton LJ III, Kearns AE, Atkinson EJ, et al. Secular trends in hip fracture incidence and recurrence. Osteoporos Int 2009; 20: 687–694.
38. Ettinger B, Black DN, Dawson-Hughes B, et al. Updated fracture incidence rates for the US version of FRAXR. Osteoporos Int 2010; 21: 25–33.
39. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fracture have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721–739.
40. Barrett-Connor E, Sajjan SG, Siris E, et al. Wrist fracture as predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 2008; 19: 807–813.
41. Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 2007; 297: 387–394.
42. Hodsman AB, Leslie WD, Tsang JF, et al. 10-Year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort. Arch Intern Med 2008; 168: 2261–2267.
43. Langsetmo L, Goldtzman D, Kovacs CS, et al., and the CaMos Research Group. Repeat low- trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 2009; 24: 1515–1522.
44. Sornay-Rendu E, Munoz F, Duboeuf F, et al. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women. J Bone Miner Res 2005; 20: 1929–1935.
45. List of US states by incomes. Available at: http://www.enwikipedia.org/wiki/. Accessed May 16, 2011.
46. Schneyer CR, Lopez H, Concannon M, et al. Assessing population risk for postmenopausal osteoporosis: a new strategy using data from the Behavioral Risk Factor Surveillance System (BRFSS). J Bone Miner Res 2008; 23: 151–158.
47. US Census Bureau. Population estimates. October 4, 2010. Available at: http://www.census.gov/popest/estbygeo.html. Accessed August 14, 2011.
48. Centers for Disease Control and Prevention. Data and Statistics. Behavioral Risk Factor Surveillance System. Available at: http://www.CDC.gov/nebddd/fasd/data.html. Accessed August 15, 2011.
